Related Experiment Video
Updated: May 2, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
The association between postoperative nadir serum potassium and mortality within 28-day after aortic valve
Haoran Zhang1, Shurui Zhang1, Shuyuxuan Song1
1Shandong First Medical University, Ji'nan City, Shandong Province, China.
Background:
This study aimed to investigate the association between postoperative nadir serum potassium and 28-day mortality in patients undergoing surgical aortic valve replacement (SAVR) using the Medical Information Mart for Intensive Care (MIMIC-IV) database.
Methods:
A retrospective cohort study included 2,877 patients undergoing SAVR from MIMIC-IV. The independent variable was postoperative nadir serum potassium, and the primary outcome was 28-day all-cause mortality. Logistic regression models adjusted for sex, age, BMI, use of beta-blockers, antidiabetic drugs, diuretics, comorbidities (COPD, heart failure, peripheral vascular disease), and indexes of kidney (BUN, Creatinine). Restricted cubic spline (RCS) regression assessed the potential nonlinear relationship, and Kaplan-Meier survival curves compared mortality risk across different serum potassium levels.
Results:
A U-shaped relationship was observed between postoperative nadir potassium and 28-day all-cause mortality. Higher nadir potassium levels were significantly associated with reduced mortality (odds ratio [OR] = 0.40, 95% confidence interval [CI]: 0.24-0.69, p < 0.001). The optimal threshold was 3.55 mmol/L; patients below this level had a markedly increased risk of death.
Conclusion:
Lower postoperative nadir serum potassium is independently associated with increased 28-day mortality in SAVR patients. Maintaining postoperative nadir serum potassium no lower than 3.5 mmol/L may be associated with reduced short-term mortality, although this threshold should not be interpreted as a target level to be constantly maintained. The nadir value represents only the lowest single measurement during ICU stay and does not reflect overall potassium homeostasis.
Insights
Lower postoperative nadir serum potassium levels are linked to higher 28-day mortality in surgical aortic valve replacement (SAVR) patients. Maintaining potassium above 3.5 mmol/L may reduce short-term mortality risk.
Area of Science:
- Cardiology
- Intensive Care Medicine
- Nephrology
Background:
- Postoperative serum potassium levels are critical in cardiac surgery patients.
- Understanding the association between nadir potassium and mortality after SAVR is essential for patient management.
Purpose of the Study:
- To investigate the relationship between postoperative nadir serum potassium and 28-day mortality in patients undergoing SAVR.
- To identify potential thresholds for serum potassium that impact short-term survival.
Main Methods:
- Retrospective cohort study of 2,877 patients undergoing SAVR from the MIMIC-IV database.
- Logistic regression and restricted cubic spline analysis were used to assess the association between nadir potassium and 28-day mortality.
- Kaplan-Meier survival curves were employed to compare mortality risks.
Main Results:
- A U-shaped relationship was found between postoperative nadir potassium and 28-day mortality.
- Higher nadir potassium levels were associated with significantly reduced mortality (OR=0.40, p<0.001).
- An optimal threshold of 3.55 mmol/L was identified, with levels below this associated with increased mortality risk.
Conclusions:
- Lower postoperative nadir serum potassium is an independent predictor of increased 28-day mortality in SAVR patients.
- Maintaining postoperative nadir serum potassium above 3.5 mmol/L may be associated with reduced short-term mortality.
- The nadir value should not be considered a target, as it represents the lowest single measurement and not overall potassium balance.
More Related Videos
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Aneurysm IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Kidney Injury VI: Nursing Management
Antihypertensive Drugs: Potassium-Sparing Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention

